Anest. intenziv. Med. 2009;20(1):25-29

Dosage and administration of antibiotics in critically ill patientsIntesive Care Medicine - Review Article

Chytra Ivan*, Štěpán Martin
Anesteziologicko-resuscitační klinika LF UK a Fakultní nemocnice v Plzni

Early and appropriate antibacterial therapy is a principal intervention in septic patients. Adequate fluid resuscitation in the hyperdynamic stage of sepsis increases renal perfusion and via increased capillary permeability leads to a leak into the third space. The increased clearance and volume of distribution may result in low plasmatic concentration of antimicrobial drugs. Alternatively, sepsis can induce multiple organ dysfunction (kidney, liver), causing a decrease of antimicrobial drug clearance with increased risk of toxic effects.
To optimize antibacterial therapy, clinician must know the properties of the used antibiotics and how these may be affected by the pathophysiological changes occurring during sepsis.

Keywords: antimicrobial therapy; sepsis; pathophysiological changes; pharmacokinetic and pharmacodynamic parameters; dosage of antibiotics

Received: October 21, 2008; Accepted: December 7, 2008; Published: February 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Chytra I, Martin Š. Dosage and administration of antibiotics in critically ill patients. Anest. intenziv. Med. 2009;20(1):25-29.
Download citation

References

  1. Dellinger, R. P., Levy, M. M., Carlet, J. M. et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med., 2008, 34, p. 17-60. Go to original source... Go to PubMed...
  2. Lipman, J. et al. Ciprofloxacin pharmacokinetic profiles in paediatric sepsis: how much ciprofloxacin is enough? Intensive Care Med., 2002, 28, p. 493-500. Go to original source... Go to PubMed...
  3. Lipman, J. et al. Low cefpirome levels during twice daily dosing in critically ill septic patients: pharmacokinetic modelling calls for more frequent dosing. Intensive Care Med., 2001, 27, p. 363-370. Go to original source... Go to PubMed...
  4. Pinder, M., Bellomo, R., Lipman. J. Pharmacological principles of antibiotic prescription in the critically ill. Anaesth. Intensive Care, 2002, 30, p. 134-144. Go to original source... Go to PubMed...
  5. Pea, F. Pharmacokinetic considerations for antimicrobial therapy in patients receiving renal replacement therapy. Clin. Pharmacokinet., 2007, 46, p. 997-1038. Go to original source... Go to PubMed...
  6. Fisman, D. N., Kaye, K. M. Once daily dosing of aminoglycoside antibiotics. Infect. Dis. Clin. North. Am., 2000, 14, p. 475-487. Go to original source... Go to PubMed...
  7. Munckhof, W. J., Grayson, M. L., Turnidge, J. D. A meta-analysis of studies on the safety and efficacy of aminoglycosides given either once daily or as divided doses. J. Antimicrob. Chemother., 1996, 37, p. 645-663. Go to original source... Go to PubMed...
  8. Freeman, C. D., Nicolau, D. P., Belliveau, P. P. Once-daily dosing of aminoglycosides: review and recommendations for clinical practice. J. Antimicrob. Chemother., 1997, 39, p. 677-686. Go to original source... Go to PubMed...
  9. Olsen, K. M., Rudis, M. I., Rebuck, J. A. et al. Effect of once-daily dosing vs. multiple daily dosing of tobramycin on enzyme markers of nephrotoxicity. Crit. Care Med., 2004, 32, p. 1678-1682. Go to original source... Go to PubMed...
  10. Angus, B. J. et al. Pharmacokinetic-pharmacodynamic evaluation of ceftazidime continuous infusion vs intermittent bolus injection in septicaemic melioidosis. Br. J. Clin. Pharmacol., 2000, 50, p. 184-191. Go to original source... Go to PubMed...
  11. Krueger, W. A. et al. Influence of combined intravenous and topical antibiotic prophylaxis on the incidence of infections, organ dysfunctions, and mortality in critically ill surgical patients: a prospective, stratified, randomized, double-blind, placebo-controlled clinical trial. Am. J. Respir. Crit. Care Med., 2002, 15, p. 1029-1037. Go to original source... Go to PubMed...
  12. Jaruratanasirikul, S. et al. Comparison of the pharmacodynamics of meropenem in patients with ventilator-associated pneumonia following administration by 3-hour infusion or bolus injection. Antimicrob. Agents Chemother., 2005, 49, p. 1337-1339. Go to original source... Go to PubMed...
  13. Lorente, L. et al. Meropenem by continuous versus intermittent infusion in ventilator-associated pneumonia due to gram-negative bacilli. Ann. Pharmacother., 2006, 40, p. 219-223. Go to original source... Go to PubMed...
  14. Chytra, I. et al. Clinical efficacy of continuous versus intermittent administration of meropenem. Intensive Care Med., 2006, 32, Suppl. 1, p. 9.
  15. Rello, J. et al. Pneumonia caused by oxacillin-resistant Staphylococcus aureus treated with glycopeptides. Crit. Care Med., 2005, 33, p. 1983-1987. Go to original source... Go to PubMed...
  16. Wysocki, M., Delatour, F., Faurisson, F. et al. Continuous versus intermittent infusion of vancomycin in severe Staphylococcal infections: prospective multicenter randomized study. Antimicrob. Agents Chemother., 2001, 45, p. 2460-2467. Go to original source... Go to PubMed...




Anesteziologie a intenzivní medicína

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.